While discussions about cardiovascular health typically center on factors like ApoB levels, high cholesterol, insulin resistance, elevated triglycerides, and high blood pressure, the impact of liver disease is often overlooked. However, recent research published in Clinical Gastroenterology and Hepatology suggests that liver health should indeed be a more prominent part of this conversation.
The study revealed that individuals with fatty liver disease exhibited significantly more dangerous arterial plaque and faced nearly double the risk of major cardiovascular events when compared to those without the condition.
Fatty Liver Disease: A Marker for More Hazardous Arterial Plaque
This investigation involved analyzing data from over 3,600 adults who were part of the PROMISE trial, a large-scale multicenter study focused on patients being evaluated for chest pain. The researchers utilized cardiac CT scans, which allowed them to assess both the heart and accessible portions of the liver.
Approximately one in four participants were diagnosed with hepatic steatosis, the medical term for fatty liver disease.
A closer examination of the plaque composition within the coronary arteries was then conducted. This differentiation is crucial because plaque behavior varies; calcified plaque is typically more stable, whereas noncalcified plaque is softer, more inflamed, and carries a higher risk of sudden rupture, potentially leading to a heart attack.
The findings indicated that individuals with fatty liver disease had considerably higher volumes of this noncalcified, high-risk plaque.
Specifically, there was a 24% increase in noncalcified plaque volume and a substantially greater overall burden of high-risk plaque compared to participants without fatty liver disease. Over the subsequent two years, these individuals also experienced significantly higher incidences of major cardiovascular events, such as heart attack, unstable angina, and mortality.
Even after accounting for conventional cardiovascular risk factors including obesity, hypertension, and diabetes, fatty liver disease remained independently associated with a 69% increased risk of major cardiac events.
These results underscore the significance of fatty liver disease, suggesting it may not merely coexist with poor metabolic health but could serve as an early indicator of more detrimental changes occurring within the cardiovascular system.
The Interplay Between Liver Disease, Metabolic Health, and Cardiovascular Risk
Chronic liver disease stands as the 11th leading cause of death globally. Furthermore, cases of metabolic dysfunction–associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease, have seen a dramatic increase of 143% since 1990, affecting an estimated 1.3 billion individuals by 2023.
Unlike many other health conditions, fatty liver disease often presents with no overt early symptoms, leading to its designation as a “silent” condition.
This condition typically develops gradually, often alongside insulin resistance, elevated triglyceride levels, the accumulation of visceral fat, poor sleep patterns, insufficient physical activity, excessive consumption of ultra-processed foods, and broader metabolic dysfunction.
Concurrently, the same metabolic pathways influencing the liver also tend to impact blood vessels. Chronic inflammation, dysregulated blood sugar control, oxidative stress, and abnormal lipid metabolism create an environment that progressively compromises arterial wall integrity.
The researchers propose that fatty liver disease may be a component of a more extensive “liver-heart axis,” where metabolic dysfunction in one organ mirrors heightened systemic stress across the cardiovascular network.
Strategies for Reversing Fatty Liver Disease
Fatty liver disease often demonstrates considerable responsiveness to lifestyle modifications, particularly when addressed in its earlier stages.
A primary objective is the reduction of visceral fat, the deeper abdominal fat strongly linked to insulin resistance and the buildup of fat in the liver. Contrary to common assumptions, this does not always necessitate drastic weight loss. Resistance training can be particularly effective, as increased muscle mass enhances the body’s capacity to regulate blood sugar and lipids.
Augmenting overall physical activity is also vital. Prolonged periods of inactivity exacerbate insulin resistance, whereas regular practices like walking, movement after meals, and aerobic exercise contribute to lowering liver fat and triglyceride levels over time.
From a nutritional standpoint, the focus should be on improving overall metabolic health. Key dietary considerations include:
- Increasing protein intake to support muscle maintenance and blood sugar stability.
- Prioritizing fiber-rich foods such as legumes, vegetables, oats, berries, and whole grains.
- Minimizing the consumption of ultra-processed foods and added sugars.
- Moderating alcohol intake, which can exacerbate liver stress.
- Enhancing sleep quality, as poor sleep significantly influences insulin sensitivity and inflammation.
Key Takeaways for Professionals
A critical insight from this study is the importance of not overlooking early indicators of health issues. Fatty liver disease is frequently underestimated due to its prevalence and often asymptomatic onset. However, even mildly elevated liver enzymes or incidental findings of “fatty liver” on imaging may signal significant underlying metabolic and cardiovascular health concerns well before overt symptoms manifest.
Business Style Takeaway: Recognizing fatty liver disease as a potential indicator of broader cardiovascular risk can prompt proactive lifestyle interventions for executives. Integrating regular physical activity, a nutrient-dense diet, and prioritizing sleep can enhance metabolic function, mitigate arterial plaque development, and ultimately bolster long-term cognitive performance and stress resilience.
Original article : www.mindbodygreen.com